Trial intelligence / Profile preview

MARS: Montelukast or Azithromycin in Childhood Asthma

NCT00471809Phase 4Terminated

Sponsor
National Heart, Lung, and Blood Institute
Start
Mar 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of azithromycin, montelukast in asthma, sponsored by National Heart, Lung, and Blood Institute. Started Mar 2006; status: terminated.

02

Drugs

azithromycinmontelukast
03

Conditions

asthma

Beyond the preview

Go deeper on NCT00471809.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00471809.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call